Chromophobe renal cell carcinoma with sarcomatoid differentiation

Scott R Lauer, Ming Zhou, Viraj A. Master, Adeboye O. Osunkoya

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

OBJECTIVE: To investigate the clinicopathologic features of chromophobe renal cell carcinoma with sarcomatoid differentiation. STUDY DESIGN: A search was made through the surgical pathology and expert consult files of two major academic institutions from 2003 to 2011 for cases of chromophobe renal cell carcinoma with sarcomatoid differentiation. RESULTS: Fourteen patients were identified. The patients included 9 males (64%) and 5 females (36%). The mean patient age was 60.4 years (range, 40-82 years). There was a left-sided predominance: left (9 patients) and right (5 patients). The mean tumor size was 14.6 cm (range, 9.5-28.0 cm), and the mean percentage sarcomatoid differentiation was 67% (range, 30-99%). All tumors exhibited moderate to extensive areas of necrosis. The nonsarcomatoid component in all cases demonstrated classic features of chromophobe renal cell carcinoma. Nine patients (64%) had pT3 disease and 5 patients (36%) had pT4 disease. Five patients (36%) had positive surgical margins. Three patients (21%) had tissue diagnosis of metastatic disease at the time of initial surgery. Six patients (43%) had subsequent pathologic and/or radiologic evidence of multiple or isolated metastatic disease. Follow-up information was available in all 14 patients. Mean follow-up time was 16 weeks (range, 2-84 weeks). Ten of 14 patients (71%) died of disease, 9 of those within 6 months (mean survival time of 10 weeks), 3 patients (21%) were alive with disease, and only 1 patient (7%) was alive with no evidence of disease. CONCLUSION: This study is one of the largest series to date specifically examining the clinicopathologic features of sarcomatoid chromophobe renal cell carcinoma in radical nephrectomy specimens and confirms the observation that these tumors behave more aggressively than conventional clear cell renal cell carcinoma or papillary renal cell carcinoma.

Original languageEnglish (US)
Pages (from-to)77-84
Number of pages8
JournalAnalytical and Quantitative Cytology and Histology
Volume35
Issue number2
StatePublished - Apr 1 2013

Fingerprint

Renal Cell Carcinoma
Neoplasms
Surgical Pathology
Patient Rights
Nephrectomy
Necrosis
Survival Rate

Keywords

  • Chromophobe renal cell carcinoma
  • Necrosis
  • Prognosis
  • Sarcomatoid renal cell carcinoma

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Chromophobe renal cell carcinoma with sarcomatoid differentiation. / Lauer, Scott R; Zhou, Ming; Master, Viraj A.; Osunkoya, Adeboye O.

In: Analytical and Quantitative Cytology and Histology, Vol. 35, No. 2, 01.04.2013, p. 77-84.

Research output: Contribution to journalArticle

Lauer, Scott R ; Zhou, Ming ; Master, Viraj A. ; Osunkoya, Adeboye O. / Chromophobe renal cell carcinoma with sarcomatoid differentiation. In: Analytical and Quantitative Cytology and Histology. 2013 ; Vol. 35, No. 2. pp. 77-84.
@article{e2dbe7791c6f4b17b1e1565a0edfc53f,
title = "Chromophobe renal cell carcinoma with sarcomatoid differentiation",
abstract = "OBJECTIVE: To investigate the clinicopathologic features of chromophobe renal cell carcinoma with sarcomatoid differentiation. STUDY DESIGN: A search was made through the surgical pathology and expert consult files of two major academic institutions from 2003 to 2011 for cases of chromophobe renal cell carcinoma with sarcomatoid differentiation. RESULTS: Fourteen patients were identified. The patients included 9 males (64{\%}) and 5 females (36{\%}). The mean patient age was 60.4 years (range, 40-82 years). There was a left-sided predominance: left (9 patients) and right (5 patients). The mean tumor size was 14.6 cm (range, 9.5-28.0 cm), and the mean percentage sarcomatoid differentiation was 67{\%} (range, 30-99{\%}). All tumors exhibited moderate to extensive areas of necrosis. The nonsarcomatoid component in all cases demonstrated classic features of chromophobe renal cell carcinoma. Nine patients (64{\%}) had pT3 disease and 5 patients (36{\%}) had pT4 disease. Five patients (36{\%}) had positive surgical margins. Three patients (21{\%}) had tissue diagnosis of metastatic disease at the time of initial surgery. Six patients (43{\%}) had subsequent pathologic and/or radiologic evidence of multiple or isolated metastatic disease. Follow-up information was available in all 14 patients. Mean follow-up time was 16 weeks (range, 2-84 weeks). Ten of 14 patients (71{\%}) died of disease, 9 of those within 6 months (mean survival time of 10 weeks), 3 patients (21{\%}) were alive with disease, and only 1 patient (7{\%}) was alive with no evidence of disease. CONCLUSION: This study is one of the largest series to date specifically examining the clinicopathologic features of sarcomatoid chromophobe renal cell carcinoma in radical nephrectomy specimens and confirms the observation that these tumors behave more aggressively than conventional clear cell renal cell carcinoma or papillary renal cell carcinoma.",
keywords = "Chromophobe renal cell carcinoma, Necrosis, Prognosis, Sarcomatoid renal cell carcinoma",
author = "Lauer, {Scott R} and Ming Zhou and Master, {Viraj A.} and Osunkoya, {Adeboye O.}",
year = "2013",
month = "4",
day = "1",
language = "English (US)",
volume = "35",
pages = "77--84",
journal = "Analytical and Quantitative Cytopathology and Histopathology",
issn = "0301-102X",
publisher = "John Rylands University Library",
number = "2",

}

TY - JOUR

T1 - Chromophobe renal cell carcinoma with sarcomatoid differentiation

AU - Lauer, Scott R

AU - Zhou, Ming

AU - Master, Viraj A.

AU - Osunkoya, Adeboye O.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - OBJECTIVE: To investigate the clinicopathologic features of chromophobe renal cell carcinoma with sarcomatoid differentiation. STUDY DESIGN: A search was made through the surgical pathology and expert consult files of two major academic institutions from 2003 to 2011 for cases of chromophobe renal cell carcinoma with sarcomatoid differentiation. RESULTS: Fourteen patients were identified. The patients included 9 males (64%) and 5 females (36%). The mean patient age was 60.4 years (range, 40-82 years). There was a left-sided predominance: left (9 patients) and right (5 patients). The mean tumor size was 14.6 cm (range, 9.5-28.0 cm), and the mean percentage sarcomatoid differentiation was 67% (range, 30-99%). All tumors exhibited moderate to extensive areas of necrosis. The nonsarcomatoid component in all cases demonstrated classic features of chromophobe renal cell carcinoma. Nine patients (64%) had pT3 disease and 5 patients (36%) had pT4 disease. Five patients (36%) had positive surgical margins. Three patients (21%) had tissue diagnosis of metastatic disease at the time of initial surgery. Six patients (43%) had subsequent pathologic and/or radiologic evidence of multiple or isolated metastatic disease. Follow-up information was available in all 14 patients. Mean follow-up time was 16 weeks (range, 2-84 weeks). Ten of 14 patients (71%) died of disease, 9 of those within 6 months (mean survival time of 10 weeks), 3 patients (21%) were alive with disease, and only 1 patient (7%) was alive with no evidence of disease. CONCLUSION: This study is one of the largest series to date specifically examining the clinicopathologic features of sarcomatoid chromophobe renal cell carcinoma in radical nephrectomy specimens and confirms the observation that these tumors behave more aggressively than conventional clear cell renal cell carcinoma or papillary renal cell carcinoma.

AB - OBJECTIVE: To investigate the clinicopathologic features of chromophobe renal cell carcinoma with sarcomatoid differentiation. STUDY DESIGN: A search was made through the surgical pathology and expert consult files of two major academic institutions from 2003 to 2011 for cases of chromophobe renal cell carcinoma with sarcomatoid differentiation. RESULTS: Fourteen patients were identified. The patients included 9 males (64%) and 5 females (36%). The mean patient age was 60.4 years (range, 40-82 years). There was a left-sided predominance: left (9 patients) and right (5 patients). The mean tumor size was 14.6 cm (range, 9.5-28.0 cm), and the mean percentage sarcomatoid differentiation was 67% (range, 30-99%). All tumors exhibited moderate to extensive areas of necrosis. The nonsarcomatoid component in all cases demonstrated classic features of chromophobe renal cell carcinoma. Nine patients (64%) had pT3 disease and 5 patients (36%) had pT4 disease. Five patients (36%) had positive surgical margins. Three patients (21%) had tissue diagnosis of metastatic disease at the time of initial surgery. Six patients (43%) had subsequent pathologic and/or radiologic evidence of multiple or isolated metastatic disease. Follow-up information was available in all 14 patients. Mean follow-up time was 16 weeks (range, 2-84 weeks). Ten of 14 patients (71%) died of disease, 9 of those within 6 months (mean survival time of 10 weeks), 3 patients (21%) were alive with disease, and only 1 patient (7%) was alive with no evidence of disease. CONCLUSION: This study is one of the largest series to date specifically examining the clinicopathologic features of sarcomatoid chromophobe renal cell carcinoma in radical nephrectomy specimens and confirms the observation that these tumors behave more aggressively than conventional clear cell renal cell carcinoma or papillary renal cell carcinoma.

KW - Chromophobe renal cell carcinoma

KW - Necrosis

KW - Prognosis

KW - Sarcomatoid renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84875800626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875800626&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 77

EP - 84

JO - Analytical and Quantitative Cytopathology and Histopathology

JF - Analytical and Quantitative Cytopathology and Histopathology

SN - 0301-102X

IS - 2

ER -